Access Programs for Fondaparinux
Drug Company Assistance
As of June 2014, GlaxoSmithKline discontinued its patient access program for fondaparinux.
ASH has not located any foundations that specifically offer assistance for patients requiring fondaparinux. If you know of a program or foundation, please contact ASH Policy and Practice Associate, Katherine Stark.